Concepta agrees to supply fertility self-test platform product to Walgreens Boots Alliance

Writer, Stock Market Wire
Tuesday, March 12, 2019 - 09:52

UK healthcare company Concepta said Tuesday it had agreed to supply its fertility and hormone self-test platform product to Walgreens Boots Alliance.

The supply agreement represented the first commercial partnership and formed part of the company's EU roll-out plans.

The company's self-test platform MyLotus recently received CE-Mark certification and the agreement would allow the company to extend its UK relationship with 'Boots the Chemist' to other Walgreens Boots Alliance partners across EU markets.

At 9:52am: (LON:CPT) Concepta Plc share price was +0.2p at 4p


Related content

Concepta raises £2.3m to fund marketing, working capital needs

Healthcare company Concepta said it had raised £2.3m via a share issue to fund marketing and provide additional working capital.

New shares in the company...

Mon, 08/04/2019 - 14:27


Concepta gets CE certification for fertility test product

Medical self-testing platform developer Concepta said it had received CE-Mark certification for its myLotus branded products for women's fertility.

Gaining the certification was a major...

Mon, 29/10/2018 - 14:05


Costain awarded connected vehicle technology contract

Infrastructure solutions company Costain said Tuesday it had been awarded a technology contract by Highways England to design, install and implement one of the UK's...

Tue, 21/08/2018 - 08:26


Concepta appoints Matthew Walls as Chairman

UK healthcare group Concepta said Tuesday, it had appointed Matthew Walls as Chairman.

Adam Reynolds, currently Chairman, is expected to move to the role...

Tue, 17/07/2018 - 10:10


Castleton swings to pretax profit buoyed by revenue, cash generation growth

Software group Castleton Technology said Tuesday it swung to a pre-tax profit in the 12 months to the end of March supported by an increase...

Tue, 19/06/2018 - 10:31